Exai Bio
PrivateLast Round
Grant
Sep 19, 2024
Est. Valuation
$130.6M
Total Funding Raised
$140.74M
Company Overview
Exai Bio is a biotechnology company that develops a liquid biopsy platform utilizing oncRNA technology and artificial intelligence for early cancer detection and personalized treatment guidance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exai Bio Comparables
Compare Exai Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precede Biosciences | 86% | |
| Flomics Biotech | 83% | |
| Hummingbird Diagnostics GmbH | 83% | |
Exai Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 19, 2024 | ||||
| Grant | Sep 25, 2023 | ||||
| Series A Extension | Oct 1, 2022 | ||||
| Series A | Dec 9, 2021 | ||||
| Grant | Apr 1, 2018 |
Exai Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A, Series A Extension |
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Blue Cross Blue Shield Association | Series A |
| Moore Strategic Ventures | Series A Extension |
| Two Sigma Ventures | Series A, Series A Extension |
| Casdin Capital | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2022
$71M round led by S32 and Casdin Capital.
- Dec 9, 2021
$68M round led by S32 and Casdin Capital.
Exai Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exai Bio's valuation, stock price, and market status.